Trial Profile
Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jul 2011
Price :
$35
*
At a glance
- Drugs Insulin suspension isophane (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Aug 2011 Results published in Diabetes, Obesity and Metabolism.
- 26 Jul 2011 New trial record